The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Lovejoy Chandra D since 2012.
The trader's CIK number is 1509420.
At the time of the last reporting, Lovejoy Chandra D was the VP of Regulatory Affairs of Sierra Oncology, Inc.. (stock ticker symbol SRRA).
Also see all insider trading activities at Sierra Oncology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | DNAI | 0 | $0 | 20,973 | $241,105 | 7,551 | $7,316 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | ECYT | 0 | $0 | 21,479 | $150,353 | 21,479 | $70,988 |
| 2013 | ECYT | 0 | $0 | 11,311 | $162,537 | 11,311 | $30,831 |
| 2012 | ECYT | 0 | $0 | 8,836 | $83,410 | 8,836 | $22,440 |
1. Sierra Oncology, Inc. (DNAI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-01-12 | DNAI | Option Ex | 7,551 | .97 | 7,316 |
| 2016-01-12 | DNAI | Sale | 20,973 | 11.50 | 241,105 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-08-11 | ECYT | Option Ex | 21,479 | 3.31 | 70,988 |
| 2014-08-11 | ECYT | Sale | 21,479 | 7.00 | 150,353 |
| 2013-08-06 | ECYT | Option Ex | 7,000 | 2.71 | 18,970 |
| 2013-08-06 | ECYT | Sale | 7,000 | 17.29 | 121,030 |
| 2013-02-25 | ECYT | Option Ex | 2,102 | 2.79 | 5,875 |
| 2013-02-25 | ECYT | Sale | 2,102 | 9.70 | 20,389 |
| 2013-01-25 | ECYT | Sale | 2,209 | 9.56 | 21,118 |
| 2013-01-25 | ECYT | Option Ex | 2,209 | 2.71 | 5,986 |
| 2012-12-26 | ECYT | Option Ex | 2,209 | 2.54 | 5,610 |
| 2012-12-26 | ECYT | Sale | 2,209 | 9.05 | 19,991 |
| 2012-11-26 | ECYT | Option Ex | 2,209 | 2.54 | 5,610 |
| 2012-11-26 | ECYT | Sale | 2,209 | 8.72 | 19,262 |
| 2012-10-25 | ECYT | Option Ex | 2,209 | 2.54 | 5,610 |
| 2012-10-25 | ECYT | Sale | 2,209 | 9.71 | 21,449 |
| 2012-09-25 | ECYT | Option Ex | 2,209 | 2.54 | 5,610 |
| 2012-09-25 | ECYT | Sale | 2,209 | 10.28 | 22,708 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lovejoy Chandra D (VP of Regulatory Affairs of Sierra Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.